Literature DB >> 18493878

Atypical cystic fibrosis and CFTR-related diseases.

Shruti M Paranjape1, Pamela L Zeitlin.   

Abstract

Cystic fibrosis (CF), which is among the most common life-shortening recessive illnesses, is caused by mutations of the CF transmembrane conductance regulator (CFTR) and typically involves chronic infection and progressive obstruction of the respiratory tract as well as pancreatic exocrine insufficiency. Disease severity, to some extent, correlates with organ sensitivity to CFTR dysfunction and to the amount of functional protein, which is influenced by the type of mutation. Atypical CF represents approximately 2% of affected individuals, and includes cases presenting in adolescence or adulthood with pancreatic exocrine sufficiency, normal or borderline sweat chloride concentrations, or with a single predominant clinical feature. This review briefly describes diagnostic methods and phenotypic characteristics of classic and atypical CF, as well as CFTR-related diseases, conditions in which mutated CFTR may contribute to the pathogenesis but do not strictly fit established diagnostic criteria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18493878     DOI: 10.1007/s12016-008-8083-0

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  37 in total

1.  What is cystic fibrosis?

Authors:  Michael R Knowles; Peter R Durie
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 2.  Atypical CF and CF related diseases.

Authors:  Eitan Kerem
Journal:  Paediatr Respir Rev       Date:  2006-06-05       Impact factor: 2.726

Review 3.  The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.

Authors:  B J Rosenstein; G R Cutting
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

4.  CFTR gene variant IVS8-5T in disseminated bronchiectasis.

Authors:  P F Pignatti; C Bombieri; M Benetazzo; A Casartelli; E Trabetti; L S Gilè; L C Martinati; A L Boner; M Luisetti
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

Review 5.  Diffuse panbronchiolitis.

Authors:  V Poletti; G Casoni; M Chilosi; M Zompatori
Journal:  Eur Respir J       Date:  2006-10       Impact factor: 16.671

6.  A study of sweat sodium and chloride; criteria for the diagnosis of cystic fibrosis.

Authors:  A Green; P Dodds; C Pennock
Journal:  Ann Clin Biochem       Date:  1985-03       Impact factor: 2.057

7.  Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.

Authors:  J A Cohn; K J Friedman; P G Noone; M R Knowles; L M Silverman; P S Jowell
Journal:  N Engl J Med       Date:  1998-09-03       Impact factor: 91.245

Review 8.  Immunomodulatory activity and effectiveness of macrolides in chronic airway disease.

Authors:  Bruce K Rubin; Markus O Henke
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

9.  DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma.

Authors:  M Dahl; A Tybjaerg-Hansen; P Lange; B G Nordestgaard
Journal:  Lancet       Date:  1998-06-27       Impact factor: 79.321

Review 10.  Nonclassic cystic fibrosis and CFTR-related diseases.

Authors:  Michael P Boyle
Journal:  Curr Opin Pulm Med       Date:  2003-11       Impact factor: 3.155

View more
  16 in total

1.  Role of CFTR mutation analysis in the diagnostic algorithm for cystic fibrosis.

Authors:  Michelle Ratkiewicz; Matthew Pastore; Karen Sharrock McCoy; Rohan Thompson; Don Hayes; Shahid Ijaz Sheikh
Journal:  World J Pediatr       Date:  2017-02-15       Impact factor: 2.764

2.  A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease.

Authors:  A D Roses; M W Lutz; H Amrine-Madsen; A M Saunders; D G Crenshaw; S S Sundseth; M J Huentelman; K A Welsh-Bohmer; E M Reiman
Journal:  Pharmacogenomics J       Date:  2009-12-22       Impact factor: 3.550

3.  Atypical presentation of cystic fibrosis at 70 years of age.

Authors:  Muhammad Adnan Saleem; Aled Phillips; Muhammad Badar Ganaie
Journal:  BMJ Case Rep       Date:  2019-06-03

4.  Exophiala dermatitidis Revealing Cystic Fibrosis in Adult Patients with Chronic Pulmonary Disease.

Authors:  Frédéric Grenouillet; Bernard Cimon; Heloise Pana-Katatali; Christine Person; Marie Gainet-Brun; Marie-Claire Malinge; Yohann Le Govic; Bénédicte Richaud-Thiriez; Jean-Philippe Bouchara
Journal:  Mycopathologia       Date:  2017-11-01       Impact factor: 2.574

5.  Functional characteristics of L1156F-CFTR associated with alcoholic chronic pancreatitis in Japanese.

Authors:  Shiho Kondo; Kotoyo Fujiki; Shigeru B H Ko; Akiko Yamamoto; Miyuki Nakakuki; Yasutomo Ito; Nikolay Shcheynikov; Motoji Kitagawa; Satoru Naruse; Hiroshi Ishiguro
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-06-18       Impact factor: 4.052

6.  Occurrence of Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations in Patients with Allergic Bronchopulmonary Aspergillosis Complicating Asthma.

Authors:  Rimjhim Kanaujia; Amit Arora; Arunaloke Chakrabarti; Shivaprakash M Rudramurthy; Ritesh Agarwal
Journal:  Mycopathologia       Date:  2022-04-16       Impact factor: 2.574

7.  Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice.

Authors:  Mathilde Beka; Teresinha Leal
Journal:  J Vis Exp       Date:  2018-07-04       Impact factor: 1.355

Review 8.  Atypical cystic fibrosis: identification in the primary care setting.

Authors:  Carrie A Schram
Journal:  Can Fam Physician       Date:  2012-12       Impact factor: 3.275

Review 9.  Cystic fibrosis: a model system for precision medicine.

Authors:  Stacey L Martiniano; Scott D Sagel; Edith T Zemanick
Journal:  Curr Opin Pediatr       Date:  2016-06       Impact factor: 2.856

10.  A Genotypic-Oriented View of CFTR Genetics Highlights Specific Mutational Patterns Underlying Clinical Macrocategories of Cystic Fibrosis.

Authors:  Marco Lucarelli; Sabina Maria Bruno; Silvia Pierandrei; Giampiero Ferraguti; Antonella Stamato; Fabiana Narzi; Annalisa Amato; Giuseppe Cimino; Serenella Bertasi; Serena Quattrucci; Roberto Strom
Journal:  Mol Med       Date:  2015-04-21       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.